Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study-Reference-Cited by-同舟云学术

Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study

Published:2024-09-06 Issue: Volume: Page:
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Kreiter Daniel^ORCID,Kalincik Tomas,Hupperts Raymond,Patti Francesco,Spitaleri Daniele,Foschi Matteo,Surcinelli Andrea,Maimone Davide,Yamout Bassem,Khoury Samia J.,Lechner-Scott Jeannette,Ozakbas Serkan,Gerlach Oliver, ,Barnett M. H.,Shaw C.,John N. A.,Buzzard K. A.,Skibina O. G.,Garber J. Y.,McCombe P. A.,Taylor B. V.,Van der Walt A.,Butzkueven H.,Grammond P.,Grand’Maison F.,Lapointe E.,Sanchez-Menoyo J. L.,Besora S.,Lugaresi A.,Onofrj M.,Amato M. P.,Alkhaboori J.,Al-Asmi A.,Boz C.,Soysal A.,Turkoglu R.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40263-024-01115-x.pdf

Reference34 articles.

1. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V, Bergers E, et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology. 2004;62:226–33.

2. Lukas C, Sombekke MH, Bellenberg B, Hahn HK, Popescu V, Bendfeldt K, et al. Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology. 2013;269:542–52.

3. Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, et al. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. Brain. 2019;142:2276–87.

4. Lauerer M, McGinnis J, Bussas M, El Husseini M, Pongratz V, Engl C, et al. Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2023. https://doi.org/10.1136/jnnp-2023-331799.

5. Rotstein D, Montalban X. Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis. Nat Rev Neurol. 2019;15:287–300.